Dopamine: a novel antitumor agent active against B-16 melanoma in vivo

N/ACitations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

L-dopa methyl ester has been shown to be an effective antitumor agent against the B-16 melanoma in vivo. We have now examined the analog, dopamine, a major catabolite of L-dopa. Dopamine administration at a daily dose of 600 mg/kg resulted in a 48% (p

Cite

CITATION STYLE

APA

Wick, M. M. (1978). Dopamine: a novel antitumor agent active against B-16 melanoma in vivo. Journal of Investigative Dermatology, 71(2), 163–164. https://doi.org/10.1111/1523-1747.ep12546959.1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free